Advanced Enzyme Technologies Limited
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Advanced Enzyme Technologies Limited's past years’ income statements indicate that its last revenue has increased compared to the previous period by 18% to $6,234,770,000. The net income raised on $1,333,050,000 and profit margin reached 21%. Total operating expenses were $2,888,490,000.

Profit Margin

Advanced Enzyme Technologies Limited (NSE:ADVENZYMES.NS): Profit margin
2011 1.16B 166.72M 14.36%
2012 1.71B 337.54M 19.71%
2015 2.22B 509.8M 22.95%
2016 2.92B 758.49M 25.92%
2018 3.87B 900.55M 23.22%
2019 4.17B 1.11B 26.59%
2021 5.00B 1.45B 29.16%
2022 5.28B 1.19B 22.61%
2024 6.23B 1.33B 21.38%

ADVENZYMES.NS Income Statement (2011 – 2023)

2023 2021 2020 2018 2017 2015 2014 2012 2011
Revenue
Revenue
6.23B5.28B5.00B4.17B3.87B2.92B2.22B1.71B1.16B
Cost of revenue
3.77B1.19B1.05B814.05M890.58M682.73M554.23M550.45M531.53M
Gross profit
2.45B4.09B3.94B3.36B2.98B2.24B1.66B1.16B629.59M
Operating exp.
Research and development
255.21M6.47M6.29M4.03M4.7M83.34M91.31M00
Selling and marketing
156.51M147.66M85.5M89.86M80.71M64.88M52.17M20.55M22.72M
Total operating expenses
2.88B2.40B1.85B1.71B1.51B932.9M842.6M580.15M441.74M
Operating income
1.72B1.66B2.03B1.63B1.47B1.31B824.34M582.00M187.85M
Other income (expenses), net
149.93M45.73M64.99M-16.47M-76.71M-126.79M-75.54M-106.23M-3.04M
Income before tax
1.87B1.71B2.10B1.61B1.38B1.18B748.09M475.77M190.89M
Income tax expense
508.7M472.59M589.07M460.61M454.11M414.34M229.96M134.92M22.23M
Net income
1.33B1.19B1.45B1.11B900.55M758.49M509.8M337.54M166.72M
Earnings per share
Basic EPS
11.9210.713.079.958.076.974.683.251.60
Diluted EPS
11.9210.6913.049.948.066.974.683.251.60
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source